Power Law company profile

Advanced Accelerator Applications

Biotech & Life Sciences · Saint-Genis-Pouilly, France · Founded 2002 · IPO 2015 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.90B

Market cap · 2026

Revenue

$239M

Latest reported FY

Investors

6 investors on Advanced Accelerator Applications's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 6 investors entered at this stage

CERN

HBM Healthcare Investments

Seventure Partners

T. Rowe Price

Tamburi Investment Partners

Adage Capital

Global footprint

Where Advanced Accelerator Applications has talent and traffic

Web traffic by country

3.6K monthly visits
across markets

🇺🇸 United States61.1%

🇮🇹 Italy13.9%

🇮🇳 India11.1%

🇩🇪 Germany11.1%

🇫🇷 France0%

Top 5 markets shown

Patent intelligence

$23M patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$23M

0.60% of market cap · comparable to top peer Centessa Pharmaceuticals ($34M)

8 active patent families

Where Advanced Accelerator Applications innovates PeptideChemical compoundSomatostatin receptorBinding affinitiesFree amino

Above peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Advanced Accelerator Applications on the five Patsnap quality dimensions

Advanced Accelerator Applications in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Advanced Accelerator Applications concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Advanced Accelerator Applications and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Advanced Accelerator Applications on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo